Classroom air cleaners could cut Kids' colds
NCT ID NCT05953233
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether portable HEPA air cleaners placed in elementary school classrooms can lower the amount of viruses in the air and reduce infections among students, teachers, and their families. About 200 participants from grades K-5 will be randomly assigned to classrooms with either working HEPA cleaners or sham cleaners that look the same but don't filter air. Researchers will track who gets sick and test for viruses in the air and in nose swabs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- HEPA air cleaner
- What this could lead to
- If it works, this could show that simple air cleaners in schools help prevent respiratory infections in children and their families.
- What could go wrong
- This is a small, early-stage study in a few schools, so results may not apply everywhere. The sham cleaners may also reduce infections, making it hard to see a clear benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Aug 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Children * Grades K-5 (age 6-12 years) * Attend one of the schools that the study team has permission to obtain classroom/school environmental samples * Have no plans to move schools within the upcoming 12 months * Subject and/or parent guardian must be able to understand and provide informed consent and also willing to participate in the study Adults * Adult (age 21 or older) parent, caretaker, or household member of child participating in this study, or teacher in classroom participating in study * Able to understand and provide informed consent Exclusion Criteria: Children * Contraindication to or inability to participate in home self-collection of nasal swab samples * Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility) * Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance * Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures Adults * Contraindication to or inability to participate in home self-collection of nasal swab samples * Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility) * Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance * Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Viral infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mass General Brigham
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may spot severe bacterial infections faster in the ER
- Can cord blood t cells be trained to stop viral infections after transplant?
- Scientists compare immune responses to viral and bacterial infections in ICU patients
- Newborn blood spots may reveal hidden risks from common virus
- Banked immune cells show promise against Life-Threatening viruses in transplant patients
- Immune cell therapy shows promise for BK virus in transplant kids